P21.07 Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non–Small Cell Lung Cancer (NSCLC)
G. Bravo Montenegro, Michael Thomas Serzan, Anas Belouali et al. · Journal of Thoracic Oncology · 2021
Cited by 2 works. doi:10.1016/j.jtho.2021.01.587 Open-access PDF